1. Home
  2. TSHA vs TWI Comparison

TSHA vs TWI Comparison

Compare TSHA & TWI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TSHA
  • TWI
  • Stock Information
  • Founded
  • TSHA 2019
  • TWI 1890
  • Country
  • TSHA United States
  • TWI United States
  • Employees
  • TSHA N/A
  • TWI N/A
  • Industry
  • TSHA Biotechnology: Pharmaceutical Preparations
  • TWI Steel/Iron Ore
  • Sector
  • TSHA Health Care
  • TWI Industrials
  • Exchange
  • TSHA Nasdaq
  • TWI Nasdaq
  • Market Cap
  • TSHA 728.4M
  • TWI 590.5M
  • IPO Year
  • TSHA 2020
  • TWI 1993
  • Fundamental
  • Price
  • TSHA $2.65
  • TWI $9.58
  • Analyst Decision
  • TSHA Strong Buy
  • TWI Strong Buy
  • Analyst Count
  • TSHA 6
  • TWI 2
  • Target Price
  • TSHA $8.17
  • TWI $11.50
  • AVG Volume (30 Days)
  • TSHA 2.6M
  • TWI 530.7K
  • Earning Date
  • TSHA 08-11-2025
  • TWI 07-31-2025
  • Dividend Yield
  • TSHA N/A
  • TWI N/A
  • EPS Growth
  • TSHA N/A
  • TWI N/A
  • EPS
  • TSHA N/A
  • TWI N/A
  • Revenue
  • TSHA $7,224,000.00
  • TWI $1,854,436,000.00
  • Revenue This Year
  • TSHA N/A
  • TWI $1.90
  • Revenue Next Year
  • TSHA N/A
  • TWI $5.32
  • P/E Ratio
  • TSHA N/A
  • TWI N/A
  • Revenue Growth
  • TSHA N/A
  • TWI 5.64
  • 52 Week Low
  • TSHA $1.05
  • TWI $5.93
  • 52 Week High
  • TSHA $3.31
  • TWI $10.94
  • Technical
  • Relative Strength Index (RSI)
  • TSHA 56.06
  • TWI 50.81
  • Support Level
  • TSHA $2.34
  • TWI $8.91
  • Resistance Level
  • TSHA $2.81
  • TWI $10.03
  • Average True Range (ATR)
  • TSHA 0.16
  • TWI 0.39
  • MACD
  • TSHA 0.01
  • TWI -0.11
  • Stochastic Oscillator
  • TSHA 67.37
  • TWI 39.35

About TSHA Taysha Gene Therapies Inc.

Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

Share on Social Networks: